Apogee Therapeutics, Inc.
APGE
Peringkat dalam Saham
#2365
Apogee Therapeutics, Inc. is a biotechnology firm, operating via its... Apogee Therapeutics, Inc. is a biotechnology firm, operating via its subsidiary, dedicated to advancing biologic treatments for conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and a range of other inflammatory and immunological disorders. Its primary focus includes APG777, a subcutaneous (SQ) monoclonal antibody (mAb) engineered for an extended half-life to treat AD, and APG808, a similarly formulated SQ extended half-life mAb targeting COPD. Furthermore, its earlier-stage pipeline features APG990, another SQ extended half-life mAb designed for AD, and APG222, comprising extended half-life subcutaneous antibodies also aimed at AD. Established in 2022, the company maintains its headquarters in Waltham, Massachusetts.
Harga Saham
$135.07
Terakhir disinkronkan: 2026-09-04
Kapitalisasi Pasar
$8.36B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
141.76%
Negara
US
Perdagangan Apogee Therapeutics, Inc. (APGE)
Kategori
Healthcare
Riwayat pemecahan saham untuk Apogee Therapeutics, Inc. (APGE)
Saham Apogee Therapeutics, Inc. (simbol: APGE) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham APGE yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham APGE.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham APGE yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham APGE.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | |||
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
